Home/Filings/4/0001099219-24-000030
4//SEC Filing

Khalaf Michel 4

Accession 0001099219-24-000030

CIK 0001099219other

Filed

Feb 6, 7:00 PM ET

Accepted

Feb 7, 4:24 PM ET

Size

12.9 KB

Accession

0001099219-24-000030

Insider Transaction Report

Form 4
Period: 2024-02-05
Khalaf Michel
President - EMEA Division
Transactions
  • Sale

    Common Stock

    2024-02-05$65.95/sh20,460$1,349,329385,987 total
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2024-02-0525,1810 total
    Exercise: $45.15Exp: 2024-02-24Common Stock (25,181 underlying)
  • Exercise/Conversion

    Common Stock

    2024-02-05$45.15/sh+25,181$1,136,922406,447 total
Footnotes (4)
  • [F1]The reporting person sold only the number of shares of MetLife, Inc.'s common stock necessary to pay the exercise price of the options exercised on February 5, 2024 and related tax obligations and fees.
  • [F2]The price reported is the weighted average price of the aggregate number of shares sold in multiple open market transactions. The shares were sold at prices between $65.94 to $65.97, inclusive. The reporting person undertakes to provide to the staff of the SEC, MetLife, Inc., or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price.
  • [F3]Includes 2,685 stock options previously added to the reporting person's award through an adjustment to maintain the intrinsic value of the stock options in light of the distribution by MetLife, Inc. to its shareholders of Brighthouse Financial, Inc. common stock. The reporting person did not receive shares of Brighthouse Financial, Inc. common stock on account of the stock options.
  • [F4]The options became exercisable in three substantially equal installments on February 25, 2015, 2016 and 2017.

Issuer

METLIFE INC

CIK 0001099219

Entity typeother

Related Parties

1
  • filerCIK 0001535491

Filing Metadata

Form type
4
Filed
Feb 6, 7:00 PM ET
Accepted
Feb 7, 4:24 PM ET
Size
12.9 KB